From 473413f00944d8ce7df1b03b08d21f8aaa34e0a6 Mon Sep 17 00:00:00 2001 From: FMS Date: Thu, 4 Apr 2024 16:24:17 +0200 Subject: [PATCH] Auto saved by Logseq --- journals/2024_04_04.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/journals/2024_04_04.md b/journals/2024_04_04.md index ba121ff5..782879b9 100644 --- a/journals/2024_04_04.md +++ b/journals/2024_04_04.md @@ -53,7 +53,7 @@ - We know that the FDC también es util para oncho, lf, scabies y demás pero tenemos que elegir una disease of particular interest to perform the particular studies. So far the achievements have been: submission to EMA through art 58. the main target is leading the way to prequalification to WHO. We did the pivotal trial that demonstrated safety efficacy against T. Trichiura. - Our current main challenges are safety and acceptability. We've had conversations with the department in Geneva to align our strategies. - Evaluation of implementation strategies, pathways to programs and an access plan. - - We look for your interes + - We look for your expertise in these 3 aspects. Our interest is go beyond the science limited to STH and a vision of global health and a program of implementation. - - - ## Cosas de gastos del [[Evento]]